Hopp til innhold
NHI.no
Annonse
Informasjon

Prognosen ved panikkangst

Prognosen ved panikkangst er god dersom du får behandling: Med behandling vil omtrent ni av ti med panikklidelse oppleve at de blir bedre eller helt friske.

lege, pasient, lettelse.jpg
Den viktigste komplikasjonen ved panikkangst er risikoen for rusmisbruk. Illustrasjonsfoto: Colourbox

Sist oppdatert:

29. mai 2020

Innhold i artikkelen

Forløpet

Ubehandlet vil en panikklidelse vanligvis bli kronisk, det vil si vedvarende. Intensiteten av plagene kan variere betydelig med perioder uten anfall, eller bare milde anfall med få symptomer.

Med behandling er prognosen god. Ni av ti vil oppleve at symptomene blir bedre eller de blir helt friske. Langtidsprognosen er best med psykologisk behandling (kognitiv atferdsterapi), men medikamentell behandling kan noen ganger også være til hjelp. Effekten av medikamentell behandling vil for mange forsvinne etter at behandlingen er avsluttet, og denne formen for behandling har mulige bivirkninger. Medikamentell behandling skal aldri gis alene, den skal gis i kombinasjon med samtaleterapi og oppfølging. Sjansen for å lykkes med behandlingen, den mer vedvarende effekten og mangelen på bivirkninger gjør at kognitiv atferdsterapi uansett er den anbefalte veien å gå.

Annonse

Mange opplever at symptomene kommer og går. Det kan være tider der du ikke har panikkanfall i det hele tatt, eller du har bare noen få anfall med mindre plagsomme symptomer. Til andre tider kan du ha to til tre anfall for uken, og symptomene er ille.

Dersom du har agorafobi i tillegg til panikklidelse er sjansen ekstra god for at du blir helt frisk med riktig behandling.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Panikklidelse . Referanselisten for dette dokumentet vises nedenfor

  1. BMJ Best Practice: Panic disorder. Nettside besøkt 05.03.19. bestpractice.bmj.com
  2. Malt U, Andressen OA, Malt EA, Melle I, Årsland D (red). Lærebok i psykiatri (s. 294). Oslo: Gyldendal akademisk, 2018.
  3. Greene AL, Eaton NR. Panic disorder and agoraphobia: A direct comparison of their multivariate comorbidity patterns. J Affect Disord. 2016 Jan 15;190:75-83. Epub 2015 Oct 9. PMID: 26480214. PubMed
  4. Asmundson GJ, Taylor S, Smits JA. Panic disorder and agoraphobia: an overview and commentary on DSM-5 changes. Depress Anxiety. 2014 Jun;31(6):480-6. Epub 2014 May 27. PMID: 24865357. PubMed
  5. Folkehelseinstituttet: Psykiske lidelser hos voksne, publisert 2014, oppdatert 03.12.21. Nettsiden besøkt 11.11.22. www.fhi.no
  6. Schumacher J, Kristensen AS, Wendland JR, Nöthen MM, Mors O, McMahon FJ, The genetics of panic disorder. J Med Genet 2011;48(6): 361-8 PubMed
  7. Kessler RC, Chiu WT, Jin R, et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2006; 63: 415-24. pmid:16585471 PubMed
  8. Ham P, Waters DB, Oliver MN. Treatment of panic disorder. Am Fam Physician 2005; 71: 733-9. PubMed
  9. Forstner AJ, Awasthi S, Wolf C, et al. Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression. Mol Psychiatry. 2021 Aug;26(8):4179-4190. Epub 2019 Nov 11. PMID: 31712720. PubMed
  10. Abelson JL, Khan S, Liberzon I, Young EA.. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety 2007; 24: 66-76. pmid:16845643 PubMed
  11. Kaufman J, Charney D. Comorbidity of mood and anxiety disorders. Depress Anxiety 2000; 12(suppl 1): 69-76.
  12. Shin J, Park DH, Ryu SH, et al. Clinical implications of agoraphobia in patients with panic disorder. Medicine (Baltimore). 2020 Jul 24;99(30):e21414. PMID: 32791758. PubMed
  13. Teismann T et al. Suicidal ideation in primary care patients suffering from panic disorder with or without agoraphobia. BMC Psychiatry 2018; 18: 305. pmid:30249220 PubMed
  14. Johnson J, Weissman MM, Klerman GL. Panic disorder, comorbidity, and suicide attempts. Arch Gen Psychiatry 1990; 47: 805-8. pmid:2393338 PubMed
  15. Leskin GA, Sheikh JI. Lifetime trauma history and panic disorder: findings from the National Comorbidity Survey. J Anxiety Disord. 2002;16:599-603. PubMed
  16. WHO: ICD-11 for Mortality and Morbidity Statistics (December 2018). 6B01 Panic disorder. Nettsiden besøkt 05.03.19. icd.who.int
  17. Herr NR, Williams JW Jr, Benjamin S, et al. Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review. JAMA. 2014;312(1):78-84. doi: 10.1001/jama.2014.5950 DOI
  18. Meuret AE, Tunnell N, Roque A. Anxiety Disorders and Medical Comorbidity: Treatment Implications. Adv Exp Med Biol. 2020;1191:237-261. PMID: 32002933. PubMed
  19. Chen J, Tsuchiya M, Kawakami N, Furukawa TA. Non-fearful vs. fearful panic attacks: a general population study from the National Comorbidity Survey. J Affect Disord. 2009 Jan;112(1-3):273-8. PMID: 18534684. PubMed
  20. Craske MG, Tsao JC. Assessment and treatment of nocturnal panic attacks. Sleep Med Rev 2005; 9: 173-84. pmid:15893248 PubMed
  21. Stein MB, Roy-Byrne PP, McQuaid JR, et al. Development of a brief diagnostic screen for panic disorder in primary care. Psychosom Med 1999; 61: 359-64. PubMed
  22. Barr Taylor C. Panic disorder. BMJ 2006; 332: 951-5. PubMed
  23. Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta‐analysis. Cochrane Database of Systematic Reviews 2016, Issue 4. Art. No.: CD011004. DOI: 10.1002/14651858.CD011004.pub2. DOI
  24. Imai H, Tajika A, Chen P, Pompoli A, Furukawa TA. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. Cochrane Database of Systematic Reviews 2016, Issue 10. Art. No.: CD011170. DOI: 10.1002/14651858.CD011170.pub2. DOI
  25. Otto MW, Tuby KS, Gould RA, McLean RY, Pollack MH. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psychiatry 2001; 158: 1989-92. American Journal of Psychiatry
  26. Bakker A, van Balkom AJ, Spinhoven P. SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr Scand 2002; 106: 163-7. PubMed
  27. Bighelli I, Castellazzi M, Cipriani A, Girlanda F, Guaiana G, Koesters M, Turrini G, Furukawa TA, Barbui C. Antidepressants versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews 2018, Issue 4. Art. No.: CD010676. DOI: 10.1002/14651858.CD010676.pub2 DOI
  28. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Panic Disorder and Agoraphobia. Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia. Aust N Z J Psychiatry 2003; 37: 642-56. PubMed
  29. Craske MG, Golinelli D, Stein MB, Roy-Byrne P, Bystritsky A, Sherbourne C. Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting? Psychol Med 2005; 35: 1645-54. PubMed
  30. Olthuis JV, Watt MC, Bailey K, Hayden JA, Stewart SH. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database of Systematic Reviews 2016, Issue 3. Art. No.: CD011565. DOI: 10.1002/14651858.CD011565.pub2. DOI
  31. Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord 2005; 88: 27-45. PubMed
  32. Westen D, Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. J Consult Clin Psychol 2001; 69: 875-99. PubMed
  33. Kenardy JA, Dow MG, Johnston DW, Newman MG, Thomson A, Taylor CB. A comparison of delivery methods of cognitive-behavioral therapy for panic disorder: an international multicenter trial. J Consult Clin Psychol 2003; 71: 1068-75. PubMed
  34. Katon WJ. Panic disorder. N Engl J Med 2006; 354: 2360-7. PubMed
  35. Virtual reality i behandling av ångestsyndrom. SBU 2021 www.sbu.se
  36. de Vries YA, Roest AM, Burgerhof JGM, de Jonge P. Initial severity and antidepressant efficacy for anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder: An individual patient data meta-analysis. Depress Anxiety 2018; 35: 515-522. pmid:29659102 PubMed
  37. Otto MW, Tuby KS, Gould RA, McLean RY, Pollack MH. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psychiatry 2001; 158: 1989-92. American Journal of Psychiatry
  38. Chawla N, Anothaisintawee T, Charoenrungrueangchai K, et al. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials. BMJ 2022; 376: e066084. pmid:35045991 PubMed
  39. Norsk legemiddelhåndbok: T5.1.1.2 Panikklidelse. Sist oppdatert 09.08.24. Nettsiden besøkt 03.07.25. www.legemiddelhandboka.no
  40. Susman J, Klee B. The role of high-potency benzodiazepines in the treatment of panic disorder. Prim Care Companion J Clin Psychiatry 2005; 7: 5-11. PubMed
  41. Breilmann J, Girlanda F, Guaiana G et al. Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews 2019, Issue 3. Art. No.: CD010677. DOI: 10.1002/14651858.CD010677.pub2 DOI
  42. Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D. Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry 2001; 58: 681-6. PubMed
  43. Jorm AF, Christensen H, Griffiths KM, Parslow RA, Rodgers B, Blewitt KA. Effectiveness of complementary and self-help treatments for anxiety disorders. Med J Aust 2004; 181: 29-46. PubMed
  44. Sareen J, Houlahan T, Cox BJ, Asmundson GJ. Anxiety disorders associated with suicidal ideation and suicide attempts in the national comorbidity survey. J Nerv Ment Dis 2005; 193: 450-4. PubMed
  45. Pilowsky DJ, Olfson M, Gameroff MJ, Wickramaratne P, Blanco C, Feder A, et al. Panic disorder and suicidal ideation in primary care. Depress Anxiety 2006; 23: 11-6. PubMed
  46. Machado S et al. Panic disorder and cardiovascular diseases: an overview. Int Rev Psychiatry 2017; 29: 436-444. pmid:28893114 PubMed
  47. Fava GA, Zielezny M, Savron G, Grandi S. Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry. 1995;166(1):87‐92. doi:10.1192/bjp.166.1.87 DOI
  48. Ballenger JC, Pecknold J, Rickels K, Sellers EM. Medication discontinuation in panic disorder. J Clin Psychiatry. 1993;54 Suppl:15‐24.
  49. Bruce SE, Yonkers KA, Otto MW, et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162: 1179-87. American Journal of Psychiatry
  50. Player MS, Peterson LE, Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med 2011;41(4): 365-77 PubMed
  51. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001 Oct. 158(10):1568-78.
  52. Gorman JM, Ken JM, Sullivan GM, Coplan JD. Neuroanatomic hypothesis of panic disorder, revised. Am J Psychiatry 2000; 157: 493-505. American Journal of Psychiatry
  53. Yonkers KA, Bruce SE, Dyck IR, Keller MB. Chronicity, relapse, and illness -- course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up. Depress Anxiety 2003; 17: 173-9. PubMed
  54. Memon MA. Panic disorder. Medscape, last updated Jan 05, 2015. emedicine.medscape.com
  55. Cloos JM. The treatment of panic disorder. Curr Opin Psychiatry. 2005;18:45-50. PubMed
Annonse
Annonse